Philips : HeartStart FR3 automated external defibrillator for professional responders treating victims of sudden cardiac arrest

November 14, 2011 – Royal Philips Electronics (NYSE: PHG, AEX: PHI) introduced Philips HeartStart FR3 automated external defibrillator (AED) in the U.S. for professional responders who treat victims of sudden cardiac arrest (SCA). As the smallest and lightest professional-grade AED among leading global manufacturers, the HeartStart FR3 is Philips’ most advanced professional-grade AED. The rugged and reliable HeartStart FR3 is designed to help make lifesaving faster and easier for professional responders. The FR3 requires a prescription for use in the United States, and must be used under medical direction.

SCA is one of the leading causes of death in the United States, claiming nearly 300,000 lives each year. Defibrillation is recognized as the only definitive treatment for ventricular fibrillation, the abnormal heart rhythm most often associated with SCA. While cardiopulmonary resuscitation (CPR) may help prolong the window of survival, CPR alone cannot restore a normal cardiac rhythm. After 10 minutes without defibrillation, few attempts to resuscitate an SCA victim are successful.

Recognizing that time-to-therapy matters, the HeartStart FR3 significantly reduces deployment time by eliminating steps to help responders start delivery of the right therapy – CPR or defibrillation – on the patient faster. The FR3 automatically powers on when the Philips HeartStart FR3 carry case is opened1. The device also features easy to access, pre-connected peel and place pads that do not require opening a foil pouch. These unique features help speed therapy delivery... Royal Philips Electronics' Press Release -